[Streptococcus pneumoniae serotypes in children with chronic inflammatory diseases of the respiratory organs]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|February 1, 1990
PubMed

Insights

Serotypes 6, 19, and 15 were most common in children with chronic bronchopulmonary diseases. New exacerbations were linked to different pneumococcal serotypes, with some penicillin resistance noted, particularly in serogroup 19.

Area of Science:

  • Microbiology
  • Pediatrics
  • Epidemiology

Background:

  • Chronic bronchopulmonary diseases in children are often associated with pneumococcal infections.
  • Understanding pneumococcal serotype prevalence is crucial for disease management and vaccine development.

Purpose of the Study:

  • To investigate the serotype distribution of Streptococcus pneumoniae strains in children with chronic bronchopulmonary diseases.
  • To analyze temporal and regional variations in pneumococcal serotypes.
  • To assess the relationship between pneumococcal serotype and disease exacerbations, and to identify antibiotic resistance patterns.

Main Methods:

  • Longitudinal study over 7 years (1982-1988).
  • Isolation and serotyping of 276 pneumococcal strains from pediatric patients.
  • Regional analysis of serotype circulation.
  • Assessment of penicillin resistance.

Main Results:

  • Serotypes 6, 19, and 15 were the most prevalent, accounting for half of all isolates.
  • Periodic fluctuations in serotype occurrence were observed.
  • Regional variations in serotype distribution were identified, with serogroups 6 and 19 being common.
  • New exacerbations of chronic bronchopulmonary disease were associated with different pneumococcal serotypes.
  • Penicillin-resistant strains (3.4%) and sensitive strains (1.8%) were detected, with most resistant strains belonging to serogroup 19.

Conclusions:

  • Pneumococcal serotype composition in children with chronic bronchopulmonary diseases is dynamic and shows regional variations.
  • The association of different serotypes with disease exacerbations suggests a complex etiological relationship.
  • The presence of penicillin resistance, particularly in serogroup 19, highlights the need for ongoing surveillance and appropriate treatment strategies.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...